Browsing by Grant Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中 >>

Browse by Funding Year 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Showing results 4 to 23 of 371

< previous next >

	Project Title	Principal Investigator	Year
4	A 10-year outcome study of an early intervention program for psychosis in Hong Kong (EASY) compare with standard care service	Chan, Kit Wa	2009/2010
5	A Genome-Wide Association Study on the Predisposition to Colorectal Cancer in the Han Chinese Population in Hong Kong	Dr Ho Judy Wai Chu	2007/2008
6	A Hong Kong adolescent alcohol control programme using simple and innovative methods to reach adolescents and parents	Ho, Daniel Sai Yin	2011/2012
7	A Multi-disciplinary Approach to Investigate Vascular Dysfunction in Obesity and Diabetes: From Molecular Mechanism to Therapeutic Intervention	Xu, Aimin	2010/2011
8	A Novel Estrogenic Protein from Edible Chinese Yam (Dioscorea Opposita Thunb.) as a Potential Drug Candidate for Relieving Menopausal Syndrome	Sze, Cho Wing	2009/2010
9	A Novel Estrogenic Protein from Edible Chinese Yam (Dioscorea Opposita Thunb.) as a Potential Drug Candidate for Relieving Menopausal Syndrome	Sze, Cho Wing	2009/2010
10	A Novel Estrogenic Protein from Edible Chinese Yam (Dioscorea Opposita Thunb.) as a Potential Drug Candidate for Relieving Menopausal Syndrome	Sze, Cho Wing	2009/2010
11	A Novel Estrogenic Protein from Edible Chinese Yam (Dioscorea Opposita Thunb.) as a Potential Drug Candidate for Relieving Menopausal Syndrome	Sze, Cho Wing	2009/2010
12	A Novel Estrogenic Protein from Edible Chinese Yam (Dioscorea Opposita Thunb.) as a Potential Drug Candidate for Relieving Menopausal Syndrome	Sze, Cho Wing	2010/2011
13	A Novel Hidden Markov Model to Predict microRNAs and their Targets Simultaneously and its Application to the Epstein-Barr virus	Wang, John Junwen	2010/2011
14	A Novel Nerve Conduit that Combines Schwann Cell-seeded Chitosan Nanofibres with Chondroitinase ABC-loaded Chitosan Microbeads for Post-traumatic Nerve Regeneration	Shum, Daisy Kwok Yan	2010/2011
15	A Novel Nerve Conduit that Combines Schwann Cell-seeded Chitosan Nanofibres with Chondroitinase ABC-loaded Chitosan Microbeads for Post-traumatic Nerve Regeneration	Shum, Daisy Kwok Yan	2011/2012
16	A Novel Vaccine for Mesothelioma Immunotherapy and Prevention;	Chen, Zhiwei	2010/2011
17	A Novel Vaccine for Tuberculosis Prevention	Chen, Zhiwei	2011/2012
18	A Phase 3, multicentre, randomized, placebo-controlled, double-bind trial of AMG 706 in combination with paclitaxel and carboplatin for advanced non-small cell lung cancer	Ho, James Chung Man	2007/2008
19	A Phase III Randomised, Double blind, Placebo controlled, Parallel, Multicentre Study to Assess the Efficacy and Safety of continuing IRESSATM 250 mg in addition to Chemotherapy versus Chemotherapy alone in Patients who have Epidermal Growth Factor Receptor (EGFR)Mutation Positive Locally advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and have progressed on First Line IRESSATM	Ho, James Chung Man	2011/2012
20	A Phase III, multi-center, placebo-controlled trial of Sorafenib (BAY 43-9006) in patients with relapsed or refractory advanced predominantly non squamous Non-Small Cell Lung Cancer (NSCLC) after 2 or 3 previous treatment regimens.	Ho, James Chung Man	2009/2010
21	A Phase III, radonmized, double-blinded, parallel group, multi centre study to access the efficacy and safety of ZD6474 (ZACTIMA TM) in combination with pemetrexed (Alimta) versus pemetrexed alone in patients with locally-advanced or metastatic (stage IIIB or IV) non-small cell lung cancer (NSCLC) after failure of 1st line anti-cancer therapy	Ho, James Chung Man	2006/2007
22	A Randomised Controlled Trial of Traditional Chinese Medicine (Yu Ping Feng San) for influenza prophylaxis in elderly residential care homes in Hong Kong	Ip, Dennis Kai Ming	2011/2012
23	A Randomized, Double-Blind, Phase 2 Study of erlotinib (Tarcevar) in combination with OSI 906 or placebo in Chemonaive Patients with Advanced NSCLC with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene	Ho, James Chung Man	2010/2011

< previous next >